These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6583196)

  • 1. Clinical perspectives on imipenem.
    Neu HC
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():149-53. PubMed ID: 6583196
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
    Mitsuhashi S
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The affinity of imipenem (N-formimidoylthienamycin) for the penicillin-binding proteins of Staphylococcus aureus--binding and release.
    Hashizume T; Park W; Matsuhashi M
    J Antibiot (Tokyo); 1984 Sep; 37(9):1049-53. PubMed ID: 6334067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    Yang Y; Bhachech N; Bush K
    J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
    Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-lactam antibiotics].
    Inoue M; Okamoto R
    Nihon Rinsho; 1990 Oct; 48(10):2178-83. PubMed ID: 2280461
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cefdinir].
    Soejima R
    Jpn J Antibiot; 1992 Oct; 45(10):1239-52. PubMed ID: 1479675
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect on growth curves and killing curves of brief exposure of Escherichia coli to imipenem and piperacillin.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():61-5. PubMed ID: 3546248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.
    Quinn JP; Dudek EJ; DiVincenzo CA; Lucks DA; Lerner SA
    J Infect Dis; 1986 Aug; 154(2):289-94. PubMed ID: 3088133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.
    Sumita Y; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 Mar; 43(3):314-20. PubMed ID: 2108953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin-binding protein (PBP) 2 and the post-antibiotic effect of carbapenems.
    Majcherczyk PA; Livermore DM
    J Antimicrob Chemother; 1990 Oct; 26(4):593-4. PubMed ID: 2254227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carbapenem antibiotics].
    Watanabe A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():737-43. PubMed ID: 12722309
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae.
    Ghosh AS; Kar AK; Kundu M
    J Antimicrob Chemother; 1999 Feb; 43(2):195-201. PubMed ID: 11252324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus.
    Sumita Y; Fukasawa M; Okuda T
    Antimicrob Agents Chemother; 1990 Mar; 34(3):484-6. PubMed ID: 2334163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.
    Matsuda K; Nakamura K; Adachi Y; Inoue M; Kawakami M
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2631-4. PubMed ID: 8592992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Penicillin-binding proteins. Their enzymatic activity and properties].
    Griaznova NS; Subbotina NA
    Antibiot Med Biotekhnol; 1986 Jul; 31(7):487-98. PubMed ID: 3532933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Penicillins].
    Aoki N
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():724-30. PubMed ID: 12722307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.